Drug
dostarlimab
Marketed as JEMPERLI.
Generic name
dostarlimab
Brand names
JEMPERLI
First FDA approval
2021-04-22
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761174 | JEMPERLI | 2021-04-22 | GLAXOSMITHKLINE |
Manufacturers
GLAXOSMITHKLINE
Frequently asked questions
When was dostarlimab FDA approved?
Earliest FDA approval on record: 2021-04-22.
What brand names are sold as dostarlimab?
JEMPERLI.
Sources
Appeal a dostarlimab denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com